Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Effective Tax Rate

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Effective Tax Rate

Insight Molecular Diagnostics Inc. (IMDX) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-26

  • Insight Molecular Diagnostics Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
  • Insight Molecular Diagnostics Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
  • Insight Molecular Diagnostics Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
  • Insight Molecular Diagnostics Inc. effective income tax rate reconciliation, percent for fiscal 2021 was 0.00%, a 100.00% decline from fiscal 2020.
Period endEffective Income Tax Rate Reconciliation, Percent 12 monthEffective Income Tax Rate Reconciliation, Percent 12 month as first filed
2025-12-310.00%
10-K · filed 2026-03-26
2024-12-310.00%
10-K · filed 2026-03-26
2023-12-310.00%
10-K · filed 2025-03-24
2021-12-310.00%
10-K · filed 2024-04-16
13.00%
10-K · filed 2022-03-11
2020-12-314.00%
10-K · filed 2022-03-11
2019-12-310.00%
10-K · filed 2021-03-19
2018-12-310.00%
10-K · filed 2020-03-26
2017-12-310.00%
10-K · filed 2019-04-01
2016-12-310.00%
10-K · filed 2018-04-02
2015-12-310.00%
10-K · filed 2018-04-02
2014-12-310.00%
10-K · filed 2017-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92